Key financial metrics and fundamentals for CRISPR Therapeutics AG (CRSP).
Market Cap
$5.35B
P/E Ratio
-8.62
Forward P/E
--
EPS
$-6.47
Forward EPS
Dividend Yield
Beta
Revenue
52-Week Low
52-Week High